Evidence map›Paper›PMID 39881864›Full record

ArticleFrontiers in pharmacology2024

Case Report: Targeted treatment by fluoxetine/norfluoxetine of a

Ping Li, Alice Butler, Yu Zhou, Karl L Magleby, Christina A Gurnett, Lawrence Salkoff

Abstract readCase Reports
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Developing a genetic return of results service core.Journal of clinical and translational science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ping LiDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO, United States.
Alice ButlerDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO, United States.
Yu ZhouDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, MO, United States.
Karl L MaglebyDepartment of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, FL, United States.
Christina A GurnettDepartment of Neurology, Division of Pediatric and Developmental Neurology at Washington University in St. Louis, MO, St. Louis, United States.
Lawrence SalkoffDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO, United States.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 2020 to 2026
$15.5M
New approaches to understanding BK channelopathies at the molecular level of single channelsR01GM149998 · NIGMS · WASHINGTON UNIVERSITY · PI MAGLEBY, KARL L, SALKOFF, LAWRENCE B · 2023 to 2024
$865k
NCATS NIH HHS UL1 TR002345NICHD NIH HHS P50 HD103525NIGMS NIH HHS R01 GM149998
6 · The paper itself

Abstract

The Kv3.2 subfamily of voltage activated potassium channels encoded by the

Indexed as

autismepilepsyfluoxetineKCNC2 electrophysiologyKv3.2norfluoxetine 4-fluoro-7-nitro-2,1,3-benzoxadiazolepotassium channelProzac

Identifiers

PMID39881864
PMCPMC11774886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.